• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于免疫基因组学设计针对 SARS-CoV-2 新变体的免疫调节多表位亚单位疫苗,并通过计算机模拟克隆和免疫模拟进行验证。

Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune simulation.

机构信息

Department of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, PR China.

Center for Biotechnology and Microbiology, University of Swat, Swat, KP, Pakistan.

出版信息

Comput Biol Med. 2021 Jun;133:104420. doi: 10.1016/j.compbiomed.2021.104420. Epub 2021 Apr 24.

DOI:10.1016/j.compbiomed.2021.104420
PMID:33930764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8064902/
Abstract

Reports of the novel and more contagious strains of SARS-CoV-2 originating in different countries have further aggravated the pandemic situation. The recent substitutions in spike protein may be critical for the virus to evade the host's immune system and therapeutics that have already been developed. Thus, this study has employed an immunoinformatics pipeline to target the spike protein of this novel strain to construct an immunogenic epitope (CTL, HTL, and B cell) vaccine against the new variant. Our investigation revealed that 12 different epitopes imparted a critical role in immune response induction. This was validated by an exploration of physiochemical properties and experimental feasibility. In silico and host immune simulation confirmed the expression and induction of both primary and secondary immune factors such as IL, cytokines, and antibodies. The current study warrants further lab experiments to demonstrate its efficacy and safety.

摘要

有关源自不同国家的新型、更具传染性的 SARS-CoV-2 变异株的报告,使大流行形势进一步恶化。刺突蛋白的最近突变可能对病毒逃避宿主免疫系统和已开发的治疗方法至关重要。因此,本研究采用免疫信息学方法针对新型变异株的刺突蛋白,构建针对新型变异株的免疫原性表位(CTL、HTL 和 B 细胞)疫苗。我们的研究表明,12 种不同的表位在免疫反应诱导中起关键作用。通过对理化性质和实验可行性的探索,验证了这一点。在计算机和宿主免疫模拟中,确认了 IL、细胞因子和抗体等主要和次要免疫因子的表达和诱导。本研究需要进一步的实验室实验来证明其疗效和安全性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2456/8064902/7a51634a3698/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2456/8064902/9523d92ac16f/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2456/8064902/b83b33af0a1c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2456/8064902/0020f6fac3ee/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2456/8064902/a5be7287d54c/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2456/8064902/fb333b158571/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2456/8064902/2a11030f4114/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2456/8064902/8e188a3dca4a/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2456/8064902/7a51634a3698/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2456/8064902/9523d92ac16f/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2456/8064902/b83b33af0a1c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2456/8064902/0020f6fac3ee/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2456/8064902/a5be7287d54c/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2456/8064902/fb333b158571/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2456/8064902/2a11030f4114/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2456/8064902/8e188a3dca4a/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2456/8064902/7a51634a3698/gr7_lrg.jpg

相似文献

1
Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune simulation.基于免疫基因组学设计针对 SARS-CoV-2 新变体的免疫调节多表位亚单位疫苗,并通过计算机模拟克隆和免疫模拟进行验证。
Comput Biol Med. 2021 Jun;133:104420. doi: 10.1016/j.compbiomed.2021.104420. Epub 2021 Apr 24.
2
Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.基于反向疫苗学的 SARS-CoV-2 多表位亚单位疫苗设计。
Infect Dis Poverty. 2020 Sep 16;9(1):132. doi: 10.1186/s40249-020-00752-w.
3
A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus.针对 SARS-CoV-2 变异株设计的保守亚单位疫苗显示出中和该病毒的证据。
Appl Microbiol Biotechnol. 2022 Jun;106(11):4091-4114. doi: 10.1007/s00253-022-11988-x. Epub 2022 May 25.
4
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.利用免疫信息学方法探索 SARS-CoV-2 的不可见抗原,设计候选多表位疫苗。
Vaccine. 2020 Nov 10;38(48):7612-7628. doi: 10.1016/j.vaccine.2020.10.016. Epub 2020 Oct 9.
5
An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.基于深度学习的多表位疫苗设计:以 SARS-CoV-2 为例的研究。
Sci Rep. 2021 Feb 5;11(1):3238. doi: 10.1038/s41598-021-81749-9.
6
designing of multi-epitope vaccine construct against human coronavirus infections.针对人类冠状病毒感染的多表位疫苗构建的设计。
J Biomol Struct Dyn. 2021 Nov;39(18):6903-6917. doi: 10.1080/07391102.2020.1804460. Epub 2020 Aug 10.
7
MERS virus spike protein HTL-epitopes selection and multi-epitope vaccine design using computational biology.使用计算生物学方法对 MERS 病毒刺突蛋白 HTL-表位进行选择和多表位疫苗设计。
J Biomol Struct Dyn. 2023;41(22):12464-12479. doi: 10.1080/07391102.2023.2191137. Epub 2023 Mar 19.
8
Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches.针对 SARS-CoV-2 的多表位疫苗:应用免疫信息学和分子动力学模拟方法。
J Biomol Struct Dyn. 2022 Apr;40(7):2917-2933. doi: 10.1080/07391102.2020.1844060. Epub 2020 Nov 9.
9
Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2.应用高通量和综合免疫信息学方法设计一种三价亚单位疫苗,以诱导针对新型人类冠状病毒 SARS-CoV、MERS-CoV 和 SARS-CoV-2 的免疫反应。
J Biomol Struct Dyn. 2022 Aug;40(13):6097-6113. doi: 10.1080/07391102.2021.1876774. Epub 2021 Jan 29.
10
A rational design of a multi-epitope vaccine against SARS-CoV-2 which accounts for the glycan shield of the spike glycoprotein.针对 SARS-CoV-2 的 Spike 糖蛋白糖盾的一种多表位疫苗的合理设计。
J Biomol Struct Dyn. 2022 Sep;40(15):7099-7113. doi: 10.1080/07391102.2021.1894986. Epub 2021 Mar 10.

引用本文的文献

1
Screening of novel therapeutic targets and chimeric vaccine construction against antibiotic-resistant .新型治疗靶点的筛选及针对抗生素耐药性的嵌合疫苗构建
Front Immunol. 2025 Jul 4;16:1555248. doi: 10.3389/fimmu.2025.1555248. eCollection 2025.
2
Molecular modeling to design a multiepitope vaccine against emerging tick-borne Yezo virus and its validation through biophysics techniques.通过分子建模设计针对新出现的蜱传耶佐病毒的多表位疫苗及其生物物理技术验证
In Silico Pharmacol. 2025 Jun 5;13(2):80. doi: 10.1007/s40203-025-00370-0. eCollection 2025.
3
Multi-Omics Analysis of the virulence factors and designing of next-generation multi-epitopes Vaccines against Rickettsia prowazekii: a computer-aided vaccine designing approach.

本文引用的文献

1
Higher infectivity of the SARS-CoV-2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data.SARS-CoV-2 新变体的传染性更高与 K417N/T、E484K 和 N501Y 突变有关:来自结构数据的见解。
J Cell Physiol. 2021 Oct;236(10):7045-7057. doi: 10.1002/jcp.30367. Epub 2021 Mar 23.
2
COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation.COVID-19 和 Toll 样受体 4(TLR4):SARS-CoV-2 可能结合并激活 TLR4 以增加 ACE2 的表达,从而促进进入并导致过度炎症。
Mediators Inflamm. 2021 Jan 14;2021:8874339. doi: 10.1155/2021/8874339. eCollection 2021.
3
普氏立克次体毒力因子的多组学分析及下一代多表位疫苗设计:一种计算机辅助疫苗设计方法
J Comput Aided Mol Des. 2025 May 26;39(1):25. doi: 10.1007/s10822-025-00603-6.
4
Design and evaluation of a multi-epitope subunit vaccine against human norovirus using an immunoinformatics approach.使用免疫信息学方法设计和评估一种针对人类诺如病毒的多表位亚单位疫苗。
Osong Public Health Res Perspect. 2025 Jun;16(3):236-251. doi: 10.24171/j.phrp.2024.0349. Epub 2025 Apr 25.
5
Bioinformatics-guided decoding of the Ancylostoma duodenale genome for the identification of potential vaccine targets.生物信息学引导下对十二指肠钩口线虫基因组进行解码以鉴定潜在疫苗靶点
BMC Genomics. 2025 May 12;26(1):468. doi: 10.1186/s12864-025-11652-4.
6
Immunoinformatic based designing of highly immunogenic multi-epitope subunit vaccines to stimulate an adaptive immune response against Junin virus.基于免疫信息学设计高免疫原性多表位亚单位疫苗以刺激针对胡宁病毒的适应性免疫反应。
Mol Divers. 2024 Dec 18. doi: 10.1007/s11030-024-11082-6.
7
Novel dual-pathogen multi-epitope mRNA vaccine development for Brucella melitensis and Mycobacterium tuberculosis in silico approach.布鲁氏菌和结核分枝杆菌新型双病原体多表位 mRNA 疫苗的计算机辅助开发
PLoS One. 2024 Oct 28;19(10):e0309560. doi: 10.1371/journal.pone.0309560. eCollection 2024.
8
A pan-genomic analysis based multi-epitope vaccine development by targeting using reverse vaccinology method: an in-silico approach.基于泛基因组分析,采用反向疫苗学方法靶向开发多表位疫苗:一种计算机模拟方法。
In Silico Pharmacol. 2024 Oct 24;12(2):93. doi: 10.1007/s40203-024-00271-8. eCollection 2024.
9
mRNA vaccine design for Epstein-Barr virus: an immunoinformatic approach.爱泼斯坦-巴尔病毒的mRNA疫苗设计:一种免疫信息学方法。
In Silico Pharmacol. 2024 Jul 24;12(2):68. doi: 10.1007/s40203-024-00244-x. eCollection 2024.
10
Development of a subunit vaccine against the cholangiocarcinoma causing : a computational approach.针对胆管癌的亚单位疫苗的研发:一种计算方法。
Front Immunol. 2024 Jul 10;15:1281544. doi: 10.3389/fimmu.2024.1281544. eCollection 2024.
Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches.
利用计算方法设计一种针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的基于多表位的下一代肽疫苗候选物。
3 Biotech. 2021 Feb;11(2):47. doi: 10.1007/s13205-020-02574-x. Epub 2021 Jan 11.
4
In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS-CoV-2 main protease (3CLpro).山奈酚作为严重急性呼吸综合征冠状病毒2主蛋白酶(3CLpro)潜在抑制剂的计算机模拟和体外评估
Phytother Res. 2021 Jun;35(6):2841-2845. doi: 10.1002/ptr.6998. Epub 2021 Jan 15.
5
New variant of SARS-CoV-2 in UK causes surge of COVID-19.英国出现的新冠病毒新变种导致新冠肺炎病例激增。
Lancet Respir Med. 2021 Feb;9(2):e20-e21. doi: 10.1016/S2213-2600(21)00005-9. Epub 2021 Jan 5.
6
Immunodominant regions prediction of nucleocapsid protein for SARS-CoV-2 early diagnosis: a bioinformatics and immunoinformatics study.基于生物信息学和免疫信息学的 SARS-CoV-2 核衣壳蛋白免疫优势区域预测用于早期诊断。
Pathog Glob Health. 2020 Dec;114(8):463-470. doi: 10.1080/20477724.2020.1838190. Epub 2020 Nov 16.
7
Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?Toll 样受体 4 是否与合并心血管代谢疾病的 COVID-19 患者的病理严重程度有关?
Cytokine Growth Factor Rev. 2021 Apr;58:102-110. doi: 10.1016/j.cytogfr.2020.09.002. Epub 2020 Sep 21.
8
Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein.严重急性呼吸综合征冠状病毒2核衣壳磷蛋白N端RNA结合结构域识别RNA机制的结构见解
Comput Struct Biotechnol J. 2020;18:2174-2184. doi: 10.1016/j.csbj.2020.08.006. Epub 2020 Aug 12.
9
Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine.基于表位的多价肽疫苗优先排序的新冠病毒刺突糖蛋白免疫信息学特征分析
J Mol Liq. 2020 Sep 15;314:113612. doi: 10.1016/j.molliq.2020.113612. Epub 2020 Jun 17.
10
Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CL).针对 SARS-CoV-2 的药物再利用研究:药物靶点 3C 样蛋白酶(3CL)的综合对接方法。
J Biomol Struct Dyn. 2021 Sep;39(15):5735-5755. doi: 10.1080/07391102.2020.1792344. Epub 2020 Jul 17.